Home / Business and Economy / Generic Advair Hits US Shelves
Generic Advair Hits US Shelves
31 Aug
Summary
- Lannett launched a generic Advair Diskus in the US.
- This is the first product from Aurobindo's inhalation pipeline.
- The drug treats asthma and chronic obstructive pulmonary disease.
Lannett Company LLC, an Aurobindo Pharma subsidiary, has successfully launched a generic equivalent of GSK plc's Advair Diskus in the United States. This significant release offers the medication in 100/50 mcg and 250/50 mcg strengths.
The debut of this generic Advair Diskus signifies a key milestone for Aurobindo Pharma, representing the initial product from its inhalation pipeline to reach the U.S. market. This achievement underscores the company's strategic commitment to expanding its portfolio of complex and specialized inhalation products.
Advair Diskus, in combination therapy, is prescribed for patients managing asthma and chronic obstructive pulmonary disease (COPD). Aurobindo Pharma had previously secured approval from the U.S. Federal Trade Commission (FTC) in June for its acquisition of the Pennsylvania-based Lannett Company.
